Transplantation, HomologousGraft vs Host DiseaseBone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation ConditioningIsoantigensLymphocyte Culture Test, MixedHematologic NeoplasmsTransplantation ChimeraGraft vs Tumor EffectT-LymphocytesGraft SurvivalTransplantation, IsogeneicWhole-Body IrradiationGraft vs Leukemia EffectStem Cell TransplantationTissue DonorsLeukemiaSkin TransplantationHistocompatibility TestingHistocompatibilityGraft vs Host ReactionTransplantation, AutologousLymphocyte ActivationBusulfanGraft RejectionTransplantation ImmunologyRecurrenceCytotoxicity, ImmunologicMice, Inbred BALB CMice, Inbred C57BLLymphocyte DepletionTreatment OutcomeImmunosuppressionRemission InductionImmunosuppressive AgentsSpleenLeukemia, Myeloid, AcuteMyeloablative AgonistsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraLeukocyte TransfusionPeripheral Blood Stem Cell TransplantationDendritic CellsVidarabineBlood Transfusion, AutologousImmune TolerancePrecursor Cell Lymphoblastic Leukemia-LymphomaAnemia, AplasticHLA AntigensLymphocytesAcute DiseaseChimerismT-Lymphocytes, CytotoxicTransplantation ToleranceHistocompatibility AntigensMyelodysplastic SyndromesMice, Inbred StrainsTime FactorsCytomegalovirus InfectionsRetrospective StudiesMice, Inbred C3HH-2 AntigensSurvival AnalysisCytotoxicity Tests, ImmunologicBlood TransfusionCD4-Positive T-LymphocytesImmunotherapy, AdoptiveKiller Cells, NaturalAllograftsMinor Histocompatibility AntigensFlow CytometryHematologic DiseasesCD8-Positive T-LymphocytesCells, CulturedSurvival RateCyclophosphamideAntilymphocyte SerumHepatic Veno-Occlusive DiseaseT-Lymphocytes, RegulatoryGraft Enhancement, ImmunologicAntigens, CDMajor Histocompatibility ComplexCyclosporineChimeraCombined Modality TherapyBone Marrow CellsImmunophenotypingLeukemia, MyeloidSiblingsImmunity, CellularInterleukin-2IsoantibodiesIslets of Langerhans TransplantationAntibodies, MonoclonalThymus GlandHost vs Graft ReactionBone MarrowSalvage TherapyMultiple Myeloma